Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Share-based Compensation (2019 - 2025)

Benitec Biopharma has reported Share-based Compensation over the past 7 years, most recently at $7.4 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $7.4 million for Q4 2025, up 135.15% from a year ago — trailing twelve months through Dec 2025 was $28.6 million (up 578.05% YoY), and the annual figure for FY2025 was $17.4 million, up 1999.52%.
  • Share-based Compensation reached $7.4 million in Q4 2025 per BNTC's latest filing, up from $5.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $10.1 million in Q2 2025 and bottomed at -$48000.0 in Q4 2022.
  • Median Share-based Compensation over the past 5 years was $255000.0 (2021), compared with a mean of $1.7 million.
  • The largest annual shift saw Share-based Compensation plummeted 120.08% in 2022 before it surged 3274.19% in 2024.
  • Over 5 years, Share-based Compensation stood at $239000.0 in 2021, then tumbled by 120.08% to -$48000.0 in 2022, then surged by 293.75% to $93000.0 in 2023, then soared by 3274.19% to $3.1 million in 2024, then surged by 135.15% to $7.4 million in 2025.
  • Business Quant data shows Share-based Compensation for BNTC at $7.4 million in Q4 2025, $5.2 million in Q3 2025, and $10.1 million in Q2 2025.